CN Bio and Pharmaron Partner to Advance Organ-on-a-Chip Technology for Drug Development
CN Bio has formed a strategic partnership with Pharmaron to validate and integrate its PhysioMimix organ-on-a-chip technology across drug discovery applications, reducing reliance on animal testing.
UK Biotech Secures €72M Series A to Advance Novel Gene Therapy for Geographic Atrophy
Complement Therapeutics has raised €72 million ($79M) in Series A funding to advance CTx001, a single-injection gene therapy targeting geographic atrophy, into Phase 1b clinical trials.
© Copyright 2025. All Rights Reserved by MedPath